These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9749071)

  • 1. [Therapeutic approach to bladder cancer classified as T3].
    Burette R
    Cancer Radiother; 1998 Apr; 2 Suppl 1():16s. PubMed ID: 9749071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of bladder cancer: assessment of the primary lesion and response to therapy.
    Reuter VE
    Prog Clin Biol Res; 1990; 353():45-56. PubMed ID: 2217426
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving concepts in muscle-invasive bladder cancer.
    Black PC; Kassouf W
    World J Urol; 2016 Jan; 34(1):1-2. PubMed ID: 26743671
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternative therapies for bladder carcinoma.
    Marshall M; Price SE; Barnhouse DH; Powell JR
    Pa Med; 1987 May; 90(5):76-8. PubMed ID: 3587987
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
    Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Bladder cancer. How can we make a difference?
    Soloway MS
    J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775
    [No Abstract]   [Full Text] [Related]  

  • 10. [The evolution of papillary tumors of the bladder. (propos of 107 cases)].
    Lakrissa A; Tazi A
    Maghrib Tibbi; 1981 Dec; 3(4):773-9. PubMed ID: 7348284
    [No Abstract]   [Full Text] [Related]  

  • 11. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
    Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
    Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
    Coblentz TR; Mills SE; Theodorescu D
    Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines for diagnosis of bladder cancer. German Society of Urology].
    Urologe A; 1998 Jul; 37(4):441-57. PubMed ID: 9738301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cancer of the bladder].
    Escudero Barrilero A
    Arch Esp Urol; 1989; 42(1):1-7. PubMed ID: 2653234
    [No Abstract]   [Full Text] [Related]  

  • 17. Bladder tumours - a review of 150 patients treated at the Institute of Urology and Nephrology General Hospital Kuala Lumpur.
    Mahamooth Z; Awang H
    Med J Malaysia; 1983 Mar; 38(1):4-8. PubMed ID: 6633334
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscle-invasive bladder tumour: can the bladder be preserved?
    Sella A
    BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder cancer: improving care with better classification and risk stratification.
    Lamm D
    J Urol; 2007 Oct; 178(4 Pt 1):1146-7. PubMed ID: 17698132
    [No Abstract]   [Full Text] [Related]  

  • 20. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.